Search for a trial

An Open Label, Randomized Phase 3 Clinical Trial of Nivolumab vs Therapy of Investigator's
Choice in Recurrent or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head
and Neck (SCCHN)

The study will look at patients with Squamous Cell Head and Neck Cancer (SCCHN) whose tumours express a certain type of protein called PD-L1. The research aims to compare a new drug called nivolumab against Investigator's choice of chemotherapy…